NCT05305495: Empagliflozin in Acute Heart Failure
- State
- Completed
- Phase
- Phase 4
- People
- 25 taking part
- Started
- 22 Dec 2022
- Primary completion
- 15 Feb 2026
- Arms
- Patients with diuretic resistance
- Results
- None posted
- 31 Mar 2022: Trial registered
- 22 Dec 2022: Trial started
- 10 Mar 2026: Trial completed